Results 211 to 220 of about 164,014 (381)

Could the chemical industry mitigate rapid global cooling from a catastrophic volcanic eruption?

open access: yesAIChE Journal, EarlyView.
Abstract Estimates based on historical data place the probability of a catastrophic volcanic eruption in the next 100 years at around one in six. Large volcanic eruptions can lead to significant global cooling for 2–4 years, with potentially devastating impacts on global agriculture.
David S. Sholl
wiley   +1 more source

Modeling heterogeneity in large‐scale bioreactors using the method of moments with a truncated normal distribution

open access: yesAIChE Journal, EarlyView.
ABSTRACT Large‐scale bioreactors in industrial bioprocesses pose challenges due to extracellular concentration gradients and intracellular heterogeneity. This study introduces a novel approach integrating the method of moments with truncated normal distributions (MM‐TND) to model intracellular heterogeneity while maintaining computational feasibility ...
Ittisak Promma   +3 more
wiley   +1 more source

Editorial: Traditionally produced fermented foods and innovative technological processes

open access: yesFrontiers in Food Science and Technology, 2023
Dele Raheem   +3 more
openaire   +2 more sources

Applied Artificial Intelligence in Materials Science and Material Design

open access: yesAdvanced Intelligent Systems, EarlyView.
AI‐driven methods are transforming materials science by accelerating material discovery, design, and analysis, leveraging large datasets to enhance predictive modeling and streamline experimental techniques. This review highlights advancements in AI applications across spectroscopy, microscopy, and molecular design, enabling efficient material ...
Emigdio Chávez‐Angel   +7 more
wiley   +1 more source

Repurposing With Purpose: Treatment of Bachmann–Bupp Syndrome With Eflornithine and Implications for Other Polyaminopathies

open access: yesAmerican Journal of Medical Genetics Part C: Seminars in Medical Genetics, EarlyView.
ABSTRACT Rare diseases impact approximately 1 in 10 people worldwide, and yet, less than 5% of all rare diseases currently have an approved treatment option available. This is due to many challenges unique to rare diseases, including small, diverse patient populations, the cost of drug development that is not proportionate to the number of patients who
Caleb P. Bupp   +7 more
wiley   +1 more source

Home - About - Disclaimer - Privacy